Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets
The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC(50) 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotoxicity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, romidepsin and psammaplin A (Figure 15A) contain disulfide bridges that are reduced in the intracellular environment to generate free thiols that are capable of Zn2+-chelation (Figure 15B) [84, 85].”
From Medicinal chemistry advances in targeting class I histone deacetylases (2023) · cites this paper as [84]
Citations
Cites
GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008) · Journal of Chemical Theory and Computation · doi:10.1021/ct700301q · Cited by 15,908
Spectrometric Identification of Organic Compounds
Silverstein, R. M., & Bassler, G. C. (1962) · Journal of Chemical Education · doi:10.1021/ed039p546 · Cited by 14,272
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006) · Bioinformatics · doi:10.1093/bioinformatics/bti770 · Cited by 6,988
Automatic atom type and bond type perception in molecular mechanical calculations
Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2005.12.005 · Cited by 5,477
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA
Ooi, S. K. T., Qiu, C., Bernstein, E., Li, K., Jia, D., Yang, Z., Erdjument-Bromage, H., Tempst, P., Lin, S.-P., Allis, C. D., et al. (2007) · Nature · doi:10.1038/nature05987 · Cited by 1,567
Histone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Dnmt3L and the Establishment of Maternal Genomic Imprints
Bourc'his, D., Xu, G.-L., Lin, C.-S., Bollman, B., & Bestor, T. H. (2001) · Science · doi:10.1126/science.1065848 · Cited by 1,439
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L
Bourc'his, D., & Bestor, T. H. (2004) · Nature · doi:10.1038/nature02886 · Cited by 1,207
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Fang, M., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. J., & Yang, C. S. (2003) · PubMed · Cited by 1,049
Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation
Jia, D., Jurkowska, R. Z., Zhang, X., Jeltsch, A., & Cheng, X. (2007) · Nature · doi:10.1038/nature06146 · Cited by 846
DOCK 6: Combining techniques to model RNA–small molecule complexes
Lang, P. T., Brozell, S. R., Mukherjee, S., Pettersen, E. F., Meng, E. C., Thomas, V., Rizzo, R. C., Case, D. A., James, T. L., & Kuntz, I. D. (2009) · RNA · doi:10.1261/rna.1563609 · Cited by 743
(2002) · PubMed · Cited by 732
Exploring the Helix-Coil Transition via All-Atom Equilibrium Ensemble Simulations
Sorin, E. J., & Pande, V. S. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.051938 · Cited by 648
Watt, F., & Molloy, P. L. (1988) · Genes & Development · doi:10.1101/gad.2.9.1136 · Cited by 617
The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a
Chédin, F., Lieber, M. R., & Hsieh, C.-L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262443999 · Cited by 539
Histone Deacetylase Inhibitors
Miller, T. A., Witter, D. J., & Belvedere, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0303094 · Cited by 530
Predictive motifs derived from cytosine methyltransferases
Pósfai, J., Bhagwat, A. S., Pósfai, G., & Roberts, R. J. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.7.2421 · Cited by 491
Takiguchi, M., Achanzar, W. E., Qu, W., Li, G., & Waalkes, M. P. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00062-4 · Cited by 457
Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells
Okano, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.11.2536 · Cited by 423
Munster, P. N., Thurn, K. T., Thomas, S., Raha, P., Lacevic, M., Miller, A., Melisko, M., Ismail-Khan, R., Rugo, H., Moasser, M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.156 · Cited by 391
Lee, W. J., & Zhu, B. T. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi206 · Cited by 372
Epigenetics—An Epicenter of Gene Regulation: Histones and Histone‐Modifying Enzymes
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461346 · Cited by 316
Piña, I. C., Gautschi, J. T., Wang, G.-Y.-S., Sanders, M. L., Schmitz, F. J., France, D., Cornell-Kennon, S., Sambucetti, L. C., Remiszewski, S. W., Perez, L. B., et al. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo034248t · Cited by 311
Biological analogs. Nature of the binding sites of copper-containing proteins
Amundsen, A. R., Whelan, J., & Bosnich, B. (1977) · Journal of the American Chemical Society · doi:10.1021/ja00462a042 · Cited by 287
A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening
Wegener, D., Wirsching, F., Riester, D., & Schwienhorst, A. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00305-8 · Cited by 282
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
Bressi, J. C., Jennings, A. J., Skene, R., Wu, Y., Melkus, R., Jong, R. D., O’Connell, S., Grimshaw, C. E., Navre, M., & Gangloff, A. R. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.091 · Cited by 261
Dong, A. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.2.439 · Cited by 251
Chen, Z., Mann, J. R., Hsieh, C., Riggs, A. D., & Chédin, F. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20447 · Cited by 230
Huang, L., Sowa, Y., Sakai, T., & Pardee, A. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203963 · Cited by 209
Rescoring Docking Hit Lists for Model Cavity Sites: Predictions and Experimental Testing
Graves, A. P., Shivakumar, D. M., Boyce, S. E., Jacobson, M. P., Case, D. A., & Shoichet, B. K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.049 · Cited by 197
Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms
Li, Y., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24398 · Cited by 194
Reconstitution and Mechanism of the Stimulation of de Novo Methylation by Human DNMT3L
Kareta, M. S., Botello, Z. M., Ennis, J. J., Chou, C., & Chédin, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603140200 · Cited by 190
Kuck, D., Singh, N., Lyko, F., & Medina-Franco, J. L. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.11.050 · Cited by 176
Crystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue
Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., & Ficner, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.065 · Cited by 158
Karpf, A. R., Lasek, A. W., Ririe, T. O., Hanks, A. N., Grossman, D., & Jones, D. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.18 · Cited by 150
Quiñoá, E., & Crews, P. (1987) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)95478-9 · Cited by 148
Brominated tyrosine metabolites from an unidentified sponge
Arabshahi, L., & Schmitz, F. J. (1987) · The Journal of Organic Chemistry · doi:10.1021/jo00392a016 · Cited by 130
Vølund, A. (1978) · Biometrics · doi:10.2307/2530598 · Cited by 125
Structural Biasing Elements for In-Cell Histone Deacetylase Paralog Selectivity
Wong, J. C., Hong, R., & Schreiber, S. L. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0341440 · Cited by 115
Psammaplin A, a chitinase inhibitor isolated from the fijian marine sponge Aplysinella rhax
Tabudravu, J. N., Eijsink, V. G. H., Gooday, G. W., Jaspars, M., Komander, D., Legg, M., Synstad, B., & van Aalten, D. M. F. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00372-8 · Cited by 112
Non-hydroxamate Histone Deacetylase Inhibitors
Suzuki, T., & Miyata, N. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774454706 · Cited by 111
Suzuki, T., Nagano, Y., Kouketsu, A., Matsuura, A., Maruyama, S., Kurotaki, M., Nakagawa, H., & Miyata, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049207j · Cited by 109
Alao, J. P., Stavropoulou, A. V., Lam, E. W. ‐., Coombes, R. C., & Vigushin, D. M. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-8 · Cited by 103
Thiol-based SAHA analogues as potent histone deacetylase inhibitors
Suzuki, T., Kouketsu, A., Matsuura, A., Kohara, A., Ninomiya, S.-I., Kohda, K., & Miyata, N. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.063 · Cited by 103
Ahn, M. Y., Jung, J. H., Na, Y. J., & Kim, H. S. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.098 · Cited by 102
The Discovery of NVP-LAQ824: From Concept to Clinic
Remiszewski, S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456675 · Cited by 88
Brominated tyrosine-derived metabolites from the sponge Ianthella basta
Kazlauskas, R., Lidgard, R. O., Murphy, P., Wells, R., & Blount, J. (1981) · Australian Journal of Chemistry · doi:10.1071/ch9810765 · Cited by 88
Psammaplin A is a natural prodrug that inhibits class I histone deacetylase
Kim, D. H., Shin, J., & Kwon, H. J. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.6 · Cited by 82
Kim, D., Lee, I. S., Jung, J. H., & Yang, S. (1999) · Archives of Pharmacal Research · doi:10.1007/bf02976431 · Cited by 81
Shim, J. S., Lee, H., Shin, J., & Kwon, H. J. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.08.036 · Cited by 78
Zinc Binding in HDAC Inhibitors: A DFT Study
Wang, D., Helquist, P. M., & Wiest, O. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo070739s · Cited by 74
Epigenetic Control Using Natural Products and Synthetic Molecules
Scior, T., & Garces-Eisele, S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776361067 · Cited by 73
Park, Y., Liu, Y., Hong, J., Lee, C., Cho, H., Kim, D., Im, K. S., & Jung, J. H. (2003) · Journal of Natural Products · doi:10.1021/np030162j · Cited by 71
Crabb, S. J., Howell, M., Rogers, H., Ishfaq, M., Yurek‐George, A., Carey, K. L., Pickering, B. M., East, P., Mitter, R., Maeda, S., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.004 · Cited by 71
Novel Structural Insights into Class I and II Histone Deacetylases
Ficner, R. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609788085304 · Cited by 71
Suzuki, T., Matsuura, A., Kouketsu, A., Nakagawa, H., & Miyata, N. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.074 · Cited by 70
A series of novel, potent, and selective histone deacetylase inhibitors
JONES, P. G., Altamura, S., Chakravarty, P. K., Cecchetti, O., Francesco, R. D., Gallinari, P., Ingenito, R., Meinke, P. T., Petrocchi, A., Rowley, M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.002 · Cited by 68
Two bromotyrosine-cysteine derived metabolites from a sponge
Rodrı́guez, A. D., Akee, R. K., & Scheuer, P. J. (1987) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)96677-2 · Cited by 67
Bromotyrosine-Derived Natural and Synthetic Products as Inhibitors of Mycothiol-S-Conjugate Amidase
Nicholas, G. M., Eckman, L. L., Ray, S., Hughes, R. O., Pfefferkorn, J. A., Barluenga, S., Nicolaou, K. C., & Bewley, C. A. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00385-2 · Cited by 66
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues
García, J. L., Franci, G., Pereira, R., Benedetti, R., Nebbioso, A., Rodríguez‐Barrios, F., Gronemeyer, H., Altucci, L., & de Lera, Á. R. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.026 · Cited by 66
Kim, D., Lee, I. S., Jung, J. Y., Lee, C. O., & Choi, S. U. (1999) · PubMed · Cited by 64
Syntheses of Phosphonic Esters of Alendronate, Pamidronate and Neridronate
Guénin, E., Monteil, M., Bouchemal, N., Prangé, T., & Lecouvey, M. (2007) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200601067 · Cited by 61
Jiang, Y., Ahn, E.-Y. E., Ryu, S. H., Kim, D., Park, J.-S., Yoon, H. J., You, S., Lee, B., Lee, D., & Jung, J. H. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-70 · Cited by 61
New Bromotyrosine Metabolites from the Sponge Aplysinella rhax
Shin, J., Lee, H., Seo, Y., Rho, J., Cho, K. W., & Paul, V. J. (2000) · Tetrahedron · doi:10.1016/s0040-4020(00)00761-4 · Cited by 59
Nebbioso, A., Pereira, R., Khanwalkar, H., Matarese, F., García‐Rodríguez, J., Miceli, M., Logie, C., Kedinger, V., Ferrara, F., Stunnenberg, H. G., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0525 · Cited by 58
SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes
Saavedra, O. M., Isakovic, L., Llewellyn, D. B., Zhan, L., Bernstein, N., Claridge, S., Raeppel, F., Vaisburg, A., Elowe, N. H., Petschner, A. J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.113 · Cited by 56
Hildmann, C., Ninkovic, M., Dietrich, R., Wegener, D., Riester, D., Zimmermann, T., Birch, O. M., Bernegger, C., Loidl, P., & Schwienhorst, A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.8.2328-2339.2004 · Cited by 51
NG-Hydroxyguanidines from Primary Amines
Martin, N. I., Woodward, J. J., & Marletta, M. A. (2006) · Organic Letters · doi:10.1021/ol061454p · Cited by 46
An improved synthesis of psammaplin A
Godert, A. M., Angelino, N. J., Woloszynska‐Read, A., Morey, S. R., James, S. R., Karpf, A. R., & Sufrin, J. R. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.008 · Cited by 41
Suzuki, T., Nagano, Y., Matsuura, A., Kohara, A., Ninomiya, S.-I., Kohda, K., & Miyata, N. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.048 · Cited by 40
Baud, M. G. J., Leiser, T., Meyer‐Almes, F., & Fuchter, M. J. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00824a · Cited by 32
Self-citationSuzuki, T., Matsuura, A., Kouketsu, A., Hisakawa, S., Nakagawa, H., & Miyata, N. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.002 · Cited by 29
Synthesis of the Marine Bromotyrosine Psammaplin F and Crystal Structure of a Psammaplin A Analogue
Yang, Q.-J., Liu, D., Sun, D., Yang, S., Hu, G., Wu, Z., & Zhao, L. (2010) · Molecules · doi:10.3390/molecules15128784 · Cited by 22
Inhibition of proliferation induced by anti-sense RNA of HDAC1 in MCF-7 cells
Cao (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000166 · Cited by 1
Research works printed but not linked: 4
- Fang M. Z., 2003, Cancer Res., 63, 7563
- Kim D., 1999, Anticancer Res., 19, 4085
- Furumai R., 2002, Cancer Res., 62, 4916
- Zhu Y., 2009, Mol. Med. Rep., 2, 743
Cited by
DNA methylation inhibitors in cancer: Recent and future approaches
Gros, C., Fahy, J., Halby, L., Dufau, I., Erdmann, A., Gregoire, J.-M., Ausseil, F., Vispé, S., & Arimondo, P. B. (2012) · Biochimie · doi:10.1016/j.biochi.2012.07.025 · Cited by 245
“Nevertheless, no DNA demethylation has been highlighted in HCT116 cells [195], and, in a recent study, psammaplin A exhibited no activity on DNMT1 at 30 and 120 mM [196], in agreement with the study of Lera et al.”
ResultTrials with ‘epigenetic’ drugs: An update
Nebbioso, A., Carafa, V., Benedetti, R., & Altucci, L. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.004 · Cited by 237
“…tumor cell growth in a A549 lung xenograft mouse model, DNMT inhibi- tion was not followed by DNA demethylation and re- expression of tumor suppressor genes, suggesting that an in- tracellular target different from DNMT1 is responsible for the cytotoxic effect of the molecule (Baud et al., 2012).”
BackgroundDiscovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries
Wang, X., Huang, B., Liu, X., & Zhan, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.004 · Cited by 190
Recent progress in DNA methyltransferase inhibitors as anticancer agents
Zhang, Z., Wang, G., Li, Y., Lei, D., Xiang, J., Ouyang, L., Wang, Y., & Yang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1072651 · Cited by 162
“, 2011), and it was further confirmed that histone deacetylases are the main target of Psammaplin and not DNMT (Baud et al., 2012).”
BackgroundFahy, J., Jeltsch, A., & Arimondo, P. B. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.729579 · Cited by 115
“Most recently, it was further confirmed that histone deacetylases are the main target of psammaplin and not DNMT [75].”
Background
Metadata
- Authors
- Baud, M. G. J., Leiser, T., Haus, P., Samlal, S., Wong, A. C., Wood, R. J., Petrucci, V., Gunaratnam, M., Hughes, S. M., Buluwela, L., Turlais, F., Neidle, S., Meyer-Almes, F.-J., White, A. J. P., & Fuchter, M. J.
- Affiliations
- Imperial College London (GB)
- Darmstadt University of Applied Sciences (DE)
- Cancer Research Technology Discovery Laboratories, Wolfson Institute for Biomedical Research, The Cruciform Building, Gower Street, London WC1E 6BT, United Kingdom
- Cancer Research UK (GB)
- Department of Surgery and Cancer, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom
- Department of Chemical Engineering and Biotechnology, University of Applied Sciences, Schnittspahnstrasse 12, 64287 Darmstadt, Germany
- Corresponding author
- Fuchter, Matthew J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-02-09
- Volume
- 55
- Issue
- 4
- Pages
- 1731-1750
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2064944074
- Cited by
- 100
- References
- 81
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 8 · 2015: 12 · 2014: 7 · 2013: 6 · 2012: 7
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Physical Sciences › Chemistry › Organic Chemistry › Isoquinoline Alkaloid Synthesis
- Keywords
- psammaplin A, histone deacetylase inhibitors, HDAC1, HDAC isoform selectivity, structure-activity relationship, marine natural products, cytotoxicity, histone acetylation, DNA methyltransferase inhibition, focused libraries
- MeSH terms
- Acetylation, Antineoplastic Agents, Disulfides, DNA (Cytosine-5-)-Methyltransferases, Drug Screening Assays, Antitumor, Histones, Humans, Isoenzymes, Models, Molecular, Prodrugs, Structure-Activity Relationship, Tubulin, Tyrosine, Crystallography, X-Ray, Dimerization, Epigenesis, Genetic, Cell Line, Tumor, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.